(May 28, 2021, 12:09 PM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on May 26 said it is restricting the use of the liver disease drug Ocaliva in patients who have primary biliary cholangitis (PBC) with advanced cirrhosis of the liver due to the risk of liver failure that may require a liver transplant....